<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32455692</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3647</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21103647</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no known cure. Approximately 90% of ALS cases are sporadic, although multiple genetic risk factors have been recently revealed also in sporadic ALS (SALS). The pathological expansion of a hexanucleotide repeat in <i>chromosome 9 open reading frame 72</i> (<i>C9orf72)</i> is the most common genetic mutation identified in familial ALS, detected also in 5-10% of SALS patients. <i>C9orf72</i>-related ALS phenotype appears to be dependent on several modifiers, including demographic factors. Sex has been reported as an independent factor influencing ALS development, with men found to be more susceptible than women. Exposure to both female and male sex hormones have been shown to influence disease risk or progression. Moreover, interplay between genetics and sex has been widely investigated in ALS preclinical models and in large populations of ALS patients carrying <i>C9orf72</i> repeat expansion. In light of the current need for reclassifying ALS patients into pathologically homogenous subgroups potentially responsive to targeted personalized therapies, we aimed to review the recent literature on the role of genetics and sex as both independent and synergic factors, in the pathophysiology, clinical presentation, and prognosis of ALS. Sex-dependent outcomes may lead to optimizing clinical trials for developing patient-specific therapies for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trojsi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3790-8018</Identifier><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences; MRI Research Center SUN-FISM, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alvano</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences; MRI Research Center SUN-FISM, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonavita</LastName><ForeName>Simona</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8561-9720</Identifier><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences; MRI Research Center SUN-FISM, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedeschi</LastName><ForeName>Gioacchino</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences; MRI Research Center SUN-FISM, Universit&#xe0; degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020412" MajorTopicYN="N">Multifactorial Inheritance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019849" MajorTopicYN="N">Sex Determination Processes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72 repeat expansion</Keyword><Keyword MajorTopicYN="N">SOD1 mutations</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">gender</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">sex</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32455692</ArticleId><ArticleId IdType="pmc">PMC7279172</ArticleId><ArticleId IdType="doi">10.3390/ijms21103647</ArticleId><ArticleId IdType="pii">ijms21103647</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Takeda T., Kitagawa K., Arai K. Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology. 2020;40:40&#x2013;56. doi: 10.1111/neup.12606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12606</ArticleId><ArticleId IdType="pubmed">31802540</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Fang F., Hanby M.F., Leigh P.N., Shaw C.E., Ye W., Rijsdijk F. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller M.F., Ferrucci L., Singleton A.B., Tienari P.J., Laaksovirta H., Restagno G., Chi&#xf2; A., Traynor B.J., Nalls M.A. Genome-wide analysis of the heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:1123&#x2013;1134. doi: 10.1001/jamaneurol.2014.1184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1184</ArticleId><ArticleId IdType="pmc">PMC4566960</ArticleId><ArticleId IdType="pubmed">25023141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Moglia C., Canosa A., Manera U., D&#x2019;Ovidio F., Vasta R., Grassano M., Brunetti M., Barberis M., Corrado L., et al. ALS phenotype is influenced by age, sex, and genetics: A population-based study. Neurology. 2020;94:e802&#x2013;e810. doi: 10.1212/WNL.0000000000008869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mazzini L., D&#x2019;Alfonso S., Corrado L., Canosa A., Moglia C., Manera U., Bersano E., Brunetti M., Barberis M., et al. The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology. 2018;91:635&#x2013;642. doi: 10.1212/WNL.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape J.A., Grose J.H. The effects of diet and sex in amyotrophic lateral sclerosis. Rev. Neurol. (Paris) 2020;176:301&#x2013;315. doi: 10.1016/j.neurol.2019.09.008. pii:S0035-3787(20)30397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J., Fogh I., Westeneng H.J., Vajda A., McLaughlin R., Heverin M., Jones A., van Eijk R., Calvo A., Mazzini L., et al. C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:295&#x2013;300. doi: 10.1136/jnnp-2016-314093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314093</ArticleId><ArticleId IdType="pubmed">27663272</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F., Siciliano M., Femiano C., Santangelo G., Lunetta C., Calvo A., Moglia C., Marinou K., Ticozzi N., Ferro C., et al. Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: The effect of male sex on survival of C9orf72 positive patients. Front. Neurosci. 2019;13:485. doi: 10.3389/fnins.2019.00485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00485</ArticleId><ArticleId IdType="pmc">PMC6534038</ArticleId><ArticleId IdType="pubmed">31156370</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X.W., Broach J.R., Connor J.R., Gerhard G.S., Simmons Z. Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research. Muscle Nerve. 2014;49:786&#x2013;803. doi: 10.1002/mus.24198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24198</ArticleId><ArticleId IdType="pubmed">24488689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., van der Zee J. ALS Genes in the genomic era and their implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., van Doormaal P.T.C., Dekker A.M., Ticozzi N., Kenna B.J., Diekstra F.P., van Rheenen W., van Eijk K.R., Jones A.R., Keagle P., et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., van der Spek A.A., V&#xf5;sa U., de Jong S., Robinson M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle O., et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268&#x2013;1283. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Project MinE ALS Sequencing Consortium Project MinE: Study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 2018;26:1537&#x2013;1546. doi: 10.1038/s41431-018-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkki H. Motor Neuron Disease: New insights into genetic risk factors for amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2016;12:491. doi: 10.1038/nrneurol.2016.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.117</ArticleId><ArticleId IdType="pubmed">27492589</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh P.R., Bhatia G., Gusev A., Finucane H.K., Bulik-Sullivan B.K., Pollack S.J., Schizophrenia Working Group of Psychiatric Genomics Consortium. de Candia T.R., Hong Lee S., Wray N.R., et al. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat. Genet. 2015;47:1385&#x2013;1392. doi: 10.1038/ng.3431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3431</ArticleId><ArticleId IdType="pmc">PMC4666835</ArticleId><ArticleId IdType="pubmed">26523775</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., van Es M.A., Hennekam E.A.M., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Lewis C.M. Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum. Hered. 2011;71:281&#x2013;288. doi: 10.1159/000330167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000330167</ArticleId><ArticleId IdType="pubmed">21846995</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy N.A., Arthur K.C., Tienari P.J., Houlden H., Chi&#xf2; A., Traynor B.J. Age-related penetrance of the C9orf72 repeat expansion. Sci. Rep. 2017;7:2116. doi: 10.1038/s41598-017-02364-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02364-1</ArticleId><ArticleId IdType="pmc">PMC5437033</ArticleId><ArticleId IdType="pubmed">28522837</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Shaw P.J., Kirby J. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol. 2014;127:333&#x2013;345. doi: 10.1007/s00401-014-1251-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1251-9</ArticleId><ArticleId IdType="pmc">PMC3925297</ArticleId><ArticleId IdType="pubmed">24493408</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K., Gampawar P., Schmidt H., Nagy Z.F., Nagy D., Kliv&#xe9;nyi P., Engelhardt J.I., Sz&#xe9;ll M. Comprehensive Genetic Analysis of a Hungarian Amyotrophic Lateral Sclerosis Cohort. Front. Genet. 2019;10:732. doi: 10.3389/fgene.2019.00732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00732</ArticleId><ArticleId IdType="pmc">PMC6707335</ArticleId><ArticleId IdType="pubmed">31475037</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch C.M., Wen N., Fan C.C., Yokoyama J.S., Kouri N., Ross O.A., H&#xf6;glinger G., M&#xfc;ller U., Ferrari R., Hardy J., et al. International Frontotemporal Dementia (FTD)&#x2013;Genomics Consortium, International Collaboration for Frontotemporal Dementia, Progressive Supranuclear Palsy (PSP) Genetics Consortium, and International Parkinson&#x2019;s Disease Genomics Consortium. Selective Genetic overlap between Amyotrophic Lateral Sclerosis and diseases of the Frontotemporal Dementia spectrum. JAMA Neurol. 2018;75:860&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6043387</ArticleId><ArticleId IdType="pubmed">29630712</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E., Renton A.E., Mok K., Dopper E.G., Waite A., Rollinson S., Chi&#xf2; A., Restagno C., Nicolaou N., Simon-Sanchez J., et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Borghero G., Restagno G., Mora G., Drepper C., Traynor B.J., Sendtner M., Brunetti M., Ossola I., Calvo A., et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain. 2012;135:784&#x2013;793. doi: 10.1093/brain/awr366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr366</ArticleId><ArticleId IdType="pmc">PMC3286333</ArticleId><ArticleId IdType="pubmed">22366794</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., Heverin M., Jordan N., Kenna K., Lynch C., et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study. Lancet Neurol. 2012;11:232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Heverin M., Elamin M., Bede P., Lynch C., Kenna K., MacLaughlin R., Walsh C., Al Chalabi A., Hardimanet O. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:699&#x2013;708. doi: 10.1002/ana.23969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23969</ArticleId><ArticleId IdType="pubmed">23836460</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Conforti F.L., Zollino M., Mora G., Monsurr&#xf2; M.R., Volanti P., Marinou K., Salvi F., Corbo M., Giannini F., et al. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol. Aging. 2012;33:1848.e15&#x2013;1848.e20. doi: 10.1016/j.neurobiolaging.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.011</ArticleId><ArticleId IdType="pmc">PMC3372681</ArticleId><ArticleId IdType="pubmed">22418734</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin D.J., McMillan C.T., Brettschneider J., Libon D.J., Powers J., Rascovsky K., Toledo J.B., Boller A., Bekisz J., Chandrasekaran K., et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2013;84:163&#x2013;169. doi: 10.1136/jnnp-2012-303507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303507</ArticleId><ArticleId IdType="pmc">PMC3543474</ArticleId><ArticleId IdType="pubmed">23117491</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh M.E., Fournier C., Li Y., Polak M., Shaw L., Landers J.E., Hu W., Gearing M., Glass J.D. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology. 2016;87:1024&#x2013;1030. doi: 10.1212/WNL.0000000000003067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003067</ArticleId><ArticleId IdType="pmc">PMC5027809</ArticleId><ArticleId IdType="pubmed">27488601</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappella M., Ciotti C., Cohen-Tannoudji M., Biferi M.G. Gene Therapy for ALS-A Perspective. Int. J. Mol. Sci. 2019;20:4388. doi: 10.3390/ijms20184388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184388</ArticleId><ArticleId IdType="pmc">PMC6771059</ArticleId><ArticleId IdType="pubmed">31500113</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Bauer C.S., Moller A., Hautbergue G.M., Ferraiuolo L., Myszczynska M.A., Higginbottom A., Walsh M.J., Whitworth A.J., et al. The C9orf72 protein interacts with Rab 1 a and the ULK 1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q., Jiang J., Gendron T.F., McAlonis-Downes M., Jiang L., Taylor A., Diaz Garcia S., Ghosh Dastidar S., Rodriguez M.J., King P., et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler A.D., Tsuiji H. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain Res. 2016;1647:19&#x2013;29. doi: 10.1016/j.brainres.2016.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.004</ArticleId><ArticleId IdType="pmc">PMC5003651</ArticleId><ArticleId IdType="pubmed">27059391</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Tartaglia M.C., Moreno D., Sato C., McKeever P., Weichert A., Keith J., Robertson J., Zinman L., Rogaeva E. DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients. Acta Neuropathol. 2017;134:271&#x2013;279. doi: 10.1007/s00401-017-1713-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1713-y</ArticleId><ArticleId IdType="pmc">PMC5508035</ArticleId><ArticleId IdType="pubmed">28439722</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., Mullen B., Heckman M.G., Baker M.C., DeJesus-Hernandez M., Brown P.H., Murray M.E., Hsiung G.-Y.R., Stewart H., Karydas A.M., et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol. Aging. 2014;35:2421.e13&#x2013;2421.e17. doi: 10.1016/j.neurobiolaging.2014.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.016</ArticleId><ArticleId IdType="pmc">PMC4105839</ArticleId><ArticleId IdType="pubmed">24866401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson A.M., Rademakers R. What we know about TMEM106B in neurodegeneration. Acta Neuropathol. 2016;132:639&#x2013;651. doi: 10.1007/s00401-016-1610-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1610-9</ArticleId><ArticleId IdType="pmc">PMC5074873</ArticleId><ArticleId IdType="pubmed">27543298</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 2006;6:37&#x2013;46. doi: 10.1007/s11910-996-0008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-996-0008-9</ArticleId><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q., Zhou Q., Chen Y., Ou R.W., Cao B., Xu Y.Q., Yang J., Shang H.F. Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: A case-control study and literature review. Sci. Rep. 2017;7:44606. doi: 10.1038/srep44606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44606</ArticleId><ArticleId IdType="pmc">PMC5349524</ArticleId><ArticleId IdType="pubmed">28291249</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2:806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz M.E., McKenna-Yasek D., Sapp P.E., Chin W., Geller B., Hayden D.L., Schoenfeld D.A., Hosler B.A., Horvitz H.R., Brown R.H. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 1997;41:210&#x2013;221. doi: 10.1002/ana.410410212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410410212</ArticleId><ArticleId IdType="pubmed">9029070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;1854. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovic A., Leigh P.N. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: Correlation between genotype and clinical features. J. Neurol. Neurosurg. Psychiatry. 1996;61:565&#x2013;572. doi: 10.1136/jnnp.61.6.565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.61.6.565</ArticleId><ArticleId IdType="pmc">PMC486646</ArticleId><ArticleId IdType="pubmed">8971099</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang S.Y., Hsu J.S., Teo K.C., Li Y., Kung M.H.W., Cheah K.S.E., Chan D., Cheung K.M.C., Li M., Sham P.C., et al. Burden of rare variants in ALS genes influences survival in familial and sporadic ALS. Neurobiol. Aging. 2017;58:238.e9&#x2013;238.e15. doi: 10.1016/j.neurobiolaging.2017.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.007</ArticleId><ArticleId IdType="pubmed">28709720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: Summary and update. Hum. Mutat. 2013;34:812&#x2013;826. doi: 10.1002/humu.22319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22319</ArticleId><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Suh E.R., Van Deerlin V.M., Wood E.M., Baek Y., et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Lee E.B., Chen-Plotkin A., Swanson E., Unger T., Malunda J., Xu Y., Winton M.J., Trojanowski J.Q., et al. Dysregulation of the ALS associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Invest. 2011;121:726&#x2013;738. doi: 10.1172/JCI44867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI44867</ArticleId><ArticleId IdType="pmc">PMC3026736</ArticleId><ArticleId IdType="pubmed">21206091</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., Ling S.C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A., et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. USA. 2013;110:736&#x2013;745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Gao K., Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Marangi G., Conte A., Tasca G., Zollino M., Lattante S. New ALS-related genes expand the spectrum paradigm of Amyotrophic Lateral Sclerosis. Brain. Pathol. 2016;26:266&#x2013;275. doi: 10.1111/bpa.12354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12354</ArticleId><ArticleId IdType="pubmed">26780671</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Moll T., Ramesh T., Castelli L., Beer A., Robins H., Fox I., Niedermoser I., Van Damme P., Moisse M., et al. Mutations in the glycosyltransferase domain of GLT8D1 are associated with familial Amyotrophic Lateral Sclerosis. Cell Rep. 2019;26:2298&#x2013;2306.e5. doi: 10.1016/j.celrep.2019.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.006</ArticleId><ArticleId IdType="pmc">PMC7003067</ArticleId><ArticleId IdType="pubmed">30811981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthous J., Lu Y.-F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., Hubers A., Weydt P., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S., van der Zee J., Gijselinck I., Engelborghs S., Sieben A., Van Langenhove T., De Bleecker J., Baets J., Vandenbulcke M., Van Laere K., et al. Belgian Neurology consortium. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Brain. 2016;139:452&#x2013;467. doi: 10.1093/brain/awv358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv358</ArticleId><ArticleId IdType="pmc">PMC4805085</ArticleId><ArticleId IdType="pubmed">26674655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R., Brown P., Ravenscroft T., van Blitterswijk M., Nicholson A.M., et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 2015;130:77&#x2013;92. doi: 10.1007/s00401-015-1436-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1436-x</ArticleId><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., M&#xfc;ller K., Wieland T., Weydt P., B&#xf6;hm S., Lul&#xe9; D., H&#xfc;bers A., Neuwirth C., Weber M., Borck G., et al. NEK1 mutations in familial amyotrophic lateral sclerosis. Brain. 2016;139:e28. doi: 10.1093/brain/aww033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww033</ArticleId><ArticleId IdType="pubmed">26945885</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Mossevelde S., Dillen L., De Bleecker J.L., Moisse M., Van Damme P., Van Broeckhoven C., van der Zee J., BELNEU Consortium NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients. Neurobiol. Aging. 2017;61:255.e1&#x2013;255.e7. doi: 10.1016/j.neurobiolaging.2017.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.021</ArticleId><ArticleId IdType="pubmed">28935222</ArticleId></ArticleIdList></Reference><Reference><Citation>Black H.A., Leighton D.J., Cleary E.M., Rose E., Stephenson L., Colville S., Ross D., Warner J., Porteous M., Gorrie G.H., et al. Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiol. Aging. 2017;51:178.e11&#x2013;178.e20. doi: 10.1016/j.neurobiolaging.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5302213</ArticleId><ArticleId IdType="pubmed">28089114</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J., Baloh R.H., Milbrandt J. The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons. J. Cell Sci. 2009;122:2274&#x2013;2282. doi: 10.1242/jcs.048975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.048975</ArticleId><ArticleId IdType="pmc">PMC2723145</ArticleId><ArticleId IdType="pubmed">19509051</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Ticozzi N., Fallini C., Soragia Gkazi A., Topp S., Kenna K.P., Scotter E.L., Kost J., Keagle P., Miller J.W., et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron. 2014;84:324&#x2013;331. doi: 10.1016/j.neuron.2014.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Lin H., Wang X., Zuo Q., Qin J., Zhang P. The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. Acta Biochim. Biophys. Sin. (Shanghai) 2015;47:834&#x2013;841. doi: 10.1093/abbs/gmv076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmv076</ArticleId><ArticleId IdType="pmc">PMC4581587</ArticleId><ArticleId IdType="pubmed">26290490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Iida A., Miyake N., Nishiguchi K.M., Fujita K., Nakazawa T., Alswaid A., Albalwi M.A., Kim O.H., Cho T.J., et al. Axial spondylometaphyseal dysplasia is caused by C21orf2 mutations. PLoS ONE. 2016;11:e0150555. doi: 10.1371/journal.pone.0150555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150555</ArticleId><ArticleId IdType="pmc">PMC4790905</ArticleId><ArticleId IdType="pubmed">26974433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Horemuzova E., Iida A., Guo L., Liu Y., Matsumoto N., Nishimura G., Nordgren A., Miyake N., Tham E., et al. Axial spondylometaphyseal dysplasia is also caused by NEK1 mutations. J. Hum. Genet. 2017;62:503&#x2013;506. doi: 10.1038/jhg.2016.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jhg.2016.157</ArticleId><ArticleId IdType="pubmed">28123176</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone F., Nguyen H.P., Van Mossevelde S., Moisse M., Sieben A., Santens P., De Bleecker J., Vandenbulcke M., Engelborghs S., Baets J., et al. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Neurobiol. Aging. 2017;51:177.e9&#x2013;177.e16. doi: 10.1016/j.neurobiolaging.2016.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.12.008</ArticleId><ArticleId IdType="pubmed">28069311</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu J., Perkins E., Cashman N.R. Effects of sex and family history on the amyotrophic lateral sclerosis (ALS) multistep model. Amyotroph. Lateral Scler. 2016;17:94.</Citation></Reference><Reference><Citation>Chi&#xf2; A., Mora G., Moglia C., Manera U., Canosa A., Cammarosano S., Ilardi A., Bertuzzo D., Bersano E., Cugnasco P., et al. Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d&#x2019;Aosta Register. JAMA Neurol. 2017;74:1097&#x2013;1104. doi: 10.1001/jamaneurol.2017.1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E., Messina P., Giussani G., Logroscino G., Zoccolella S., Chi&#xf2; A., Calvo A., Corbo M., Lunetta C., Marin B., et al. Physical Activity and Amyotrophic Lateral Sclerosis: A European Population-Based Case&#x2013;Control Study. Ann. Neurol. 2014;75:708&#x2013;716. doi: 10.1002/ana.24150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24150</ArticleId><ArticleId IdType="pubmed">24706338</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly Z.R., Scott K.M., Abhinav K., Wijesekera L., Ganesalingam J., Goldstein L.H., Janssen A., Dougherty A., Willey E., Stanton B.R., et al. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph. Lateral Scler. 2010;11:439&#x2013;442. doi: 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jong S., Huisman M., Sutedja N., van der Kooi A., de Visser M., Schelhaas J., van der Schouw Y., Veldink J., van den Berget L. Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis. J. Neurol. 2013;260:507&#x2013;512. doi: 10.1007/s00415-012-6665-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6665-5</ArticleId><ArticleId IdType="pubmed">22972621</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J.P.K., Visser A.E., D&#x2019;Ovidio F., Vermeulen R., Beghi E., Chio A., Veldink J.H., Logroscino G., van den Berg L.H., Hardiman O., et al. A case-control study of hormonal exposures as etiologic factors for ALS in women Euro-MOTOR. Neurology. 2017;89:1283&#x2013;1290. doi: 10.1212/WNL.0000000000004390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004390</ArticleId><ArticleId IdType="pubmed">28835399</ArticleId></ArticleIdList></Reference><Reference><Citation>Popat R.A., Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Bloch D.A., Leimpeter A., McGuire V., Nelson L.M. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2006;27:117&#x2013;121. doi: 10.1159/000095550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000095550</ArticleId><ArticleId IdType="pubmed">16946622</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer R.M., Mayer B., Kuncl R.W., Check D.P., Cahoon E.K., Rivera D.R., Freedman D.M. Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs. Amyotroph. Lateral Sclero. Frontotemporal Degenerat. 2019:1&#x2013;11. doi: 10.1080/21678421.2019.1682613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1682613</ArticleId><ArticleId IdType="pubmed">31684770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kim T.Y., Cho K.S., Kim H.N., Koh J.Y. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;59:80&#x2013;85. doi: 10.1016/j.nbd.2013.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.07.011</ArticleId><ArticleId IdType="pubmed">23891729</ArticleId></ArticleIdList></Reference><Reference><Citation>Heitzer M., Kaiser S., Kanagaratnam M., Zendedel A., Hartmann P., Beyer C., Johann S. Administration of 17beta-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice. Mol. Neurobiol. 2017;54:8429&#x2013;8443. doi: 10.1007/s12035-016-0322-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0322-4</ArticleId><ArticleId IdType="pubmed">27957680</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivekananda U., Manjalay Z.R., Ganesalingam J., Simms J., Shaw C.E., Leigh P.N., Turner M.R., Al-Chalabi A. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J. Neurol. Neurosurg. Psychiatry. 2011;82:635&#x2013;637. doi: 10.1136/jnnp.2010.237412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.237412</ArticleId><ArticleId IdType="pubmed">21551173</ArticleId></ArticleIdList></Reference><Reference><Citation>Herron L.R., Miles G.B. Gender-specific perturbations in modulatory inputs to motoneurons in a mouse model of amyotrophic lateral sclerosis. Neuroscience. 2012;226:313&#x2013;323. doi: 10.1016/j.neuroscience.2012.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.09.031</ArticleId><ArticleId IdType="pubmed">23000617</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto A. Androgen stimulates neuronal plasticity in the perineal motoneurons of aged male rats. J. Comp. Neurol. 2011;430:389&#x2013;395. doi: 10.1002/1096-9861(20010212)430:3&lt;389::AID-CNE1038&gt;3.0.CO;2-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9861(20010212)430:3&lt;389::AID-CNE1038&gt;3.0.CO;2-3</ArticleId><ArticleId IdType="pubmed">11169475</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner L.P. Possible role of androgen receptors in amyotrophic lateral sclerosis. A hypothesis. Arch. Neurol. 1980;37:129&#x2013;131. doi: 10.1001/archneur.1980.00500520027002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1980.00500520027002</ArticleId><ArticleId IdType="pubmed">7356416</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo-Monachelli G.M., Sivori M., Meyer M., Sica R.E., De Nicola A.F., Gonzalez-Deniselle M.C. Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: Possible markers of susceptibility and outcome. Horm. Metab. Res. 2014;46:433&#x2013;439. doi: 10.1055/s-0034-1371891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1371891</ArticleId><ArticleId IdType="pubmed">24806746</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Moglia C., Mazzini L., Mora G., PARALS Study Group Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740e&#x2013;746e. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri A., Mento G., Calvo V., Querin G., D&#x2019;Ascenzo C., Volpato C., Kleinbub J.R., Bisiacchi P.S., Soraru G. Female gender doubles executive dysfunction risk in ALS: A case-control study in 165 patients. J. Neurol. Neurosurg. Psychiatry. 2015;86:574&#x2013;579. doi: 10.1136/jnnp-2014-307654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-307654</ArticleId><ArticleId IdType="pubmed">25063584</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaherty C., Kraft J., Brothers A., Harrison M., Legro R.S., Manni A., Yang C., Simmons Z. for the VALUES Consortium. The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuation. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:74&#x2013;85. doi: 10.1080/21678421.2016.1249487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1249487</ArticleId><ArticleId IdType="pubmed">27892698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E., Messina P., Logroscino G., Beghi E., The SLALOM Group Long-Term Survival in Amyotrophic Lateral Sclerosis: A Population-Based Study. Ann. Neurol. 2014;75:287&#x2013;297. doi: 10.1002/ana.24096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24096</ArticleId><ArticleId IdType="pubmed">24382602</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Strykowski R., Meyer M., Mulcrone P., Krakora D., Suzuki M. Male-specific differences in proliferation, neurogenesis, and sensitivity to oxidative stress in neural progenitor cells derived from a rat model of ALS. PLoS ONE. 2012;7:e48581. doi: 10.1371/journal.pone.0048581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048581</ArticleId><ArticleId IdType="pmc">PMC3493558</ArticleId><ArticleId IdType="pubmed">23144905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes-Punzo A., Mulcrone P., Meyer M., McHugh J., Svendsen C.N., Suzuki M. Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:311&#x2013;314. doi: 10.3109/17482968.2012.654393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.654393</ArticleId><ArticleId IdType="pmc">PMC3644484</ArticleId><ArticleId IdType="pubmed">22409357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L., Liu Y., Sun C., Zheng Q., Hao P., Zhai J., Liu Y. Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Med. Sci. Monit. 2018;24:678&#x2013;686. doi: 10.12659/MSM.908786.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.908786</ArticleId><ArticleId IdType="pmc">PMC5806477</ArticleId><ArticleId IdType="pubmed">29394243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y., Soucy G., Phaneuf D., Audet J.N., Gros-Louis F., Rouleau G.A., Blasco H., Corcia P., Andersen P.M., Nordin F., et al. Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2016;25:4771&#x2013;4786. doi: 10.1093/hmg/ddw304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw304</ArticleId><ArticleId IdType="pmc">PMC5418737</ArticleId><ArticleId IdType="pubmed">28175304</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbach J., Schwalenstocker B., Soyal S.M., Bayer H., Wiesner D., Akimoto C., Nilsson A.C., Birve A., Meyer T., Dupuis L., et al. PGC-1a is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:3477&#x2013;3484. doi: 10.1093/hmg/ddt202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt202</ArticleId><ArticleId IdType="pubmed">23669350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb H.M., Sharp P.S., Rahmani-Kondori N., Wells D.J. Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1G93A mouse model of ALS and is harmful in female mice. PLoS ONE. 2011;6:e24189. doi: 10.1371/journal.pone.0024189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024189</ArticleId><ArticleId IdType="pmc">PMC3164704</ArticleId><ArticleId IdType="pubmed">21909419</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansfield R., Galea R., Brincat M., Hole D., Mason H. Metformin has direct effects on human ovarian steroidogenesis. Fertil. Steril. 2003;79:956&#x2013;962. doi: 10.1016/S0015-0282(02)04925-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0015-0282(02)04925-7</ArticleId><ArticleId IdType="pubmed">12749437</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos S., Ram&#xed;rez-N&#xfa;&#xf1;ez O., Granado-Serrano A.B., Torres P., Ayala V., Moiseeva V., Povedano M., Ferrer I., Pamplona R., Portero-Otin M., et al. Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS. Acta Neuropathol. Commun. 2016;4:3. doi: 10.1186/s40478-015-0271-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0271-6</ArticleId><ArticleId IdType="pmc">PMC4711180</ArticleId><ArticleId IdType="pubmed">26757991</ArticleId></ArticleIdList></Reference><Reference><Citation>Riar A.K., Burstein S.R., Palomo G.M., Arreguin A., Manfredi G., Germain D. Sex specific activation of the ERalpha axis of the mitochondrial UPR (UPRmt) in the G93A-SOD1 mouse model of familial ALS. Hum. Mol. Genet. 2017;26:1318&#x2013;1327. doi: 10.1093/hmg/ddx049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx049</ArticleId><ArticleId IdType="pmc">PMC6075578</ArticleId><ArticleId IdType="pubmed">28186560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreilaus F., Guerra S., Masanetz R., Menne V., Yerbury J., Karl T. Novel behavioural characteristics of the superoxide dismutase1 G93A (SOD1G93A) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes. Genes Brain Behav. 2020;19:e12604. doi: 10.1111/gbb.12604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gbb.12604</ArticleId><ArticleId IdType="pubmed">31412164</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres P., Cacabelos D., Pairada J., Bauer K.C., Boada J., Fontdevila L., Rossi C., Povedano M., Ferrer I., Pamplona R., et al. Gender-specific beneficial effects of docosahexaenoic acid dietary supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis mice. Neurotherapeutics. 2020;17:269&#x2013;281. doi: 10.1007/s13311-019-00808-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00808-2</ArticleId><ArticleId IdType="pmc">PMC7007454</ArticleId><ArticleId IdType="pubmed">31755041</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos B., Ayala V., Ram&#x131;rez-Nunez O., Granado-Serrano A.B., Boada J., Serrano J.C.E., Cabre&#x2019; R., Nadal-Rey G., Bellmunt M.G., Ferrer I., et al. Dietary lipid unsaturation influences survival and oxidative modifications of an Amyotrophic Lateral Sclerosis model in a gender-specific manner. Neuromol. Med. 2014;16:669&#x2013;685. doi: 10.1007/s12017-014-8317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-014-8317-7</ArticleId><ArticleId IdType="pubmed">24980941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bame M., Pentiak P.A., Needleman R., Brusilow W.S.A. Effect of sex on lifespan, disease progression, and the response to Methionine Sulfoximine in the SOD1 G93A mouse model for ALS. Gend. Med. 2012;9:524&#x2013;535. doi: 10.1016/j.genm.2012.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2012.10.014</ArticleId><ArticleId IdType="pubmed">23217569</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis A.F., Masellis M., Hsiung G.R., Moineddin R., Zhang K., Au B., Millett G., Mackenzie I., Rogaeva E., Tierney M.C. Sex differences in the prevalence of genetic mutations in FTD and ALS. A meta-analysis. Neurology. 2017;89:1633&#x2013;1642. doi: 10.1212/WNL.0000000000004494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004494</ArticleId><ArticleId IdType="pmc">PMC5634668</ArticleId><ArticleId IdType="pubmed">28916533</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Fifita J.A., Vucic S., Durnall J.C., Kiernan M.C., Blair I.P., Nicholson G.A. Pathophysiological insights into ALS with C9ORF72 expansions. J. Neurol. Neurosurg. Psychiatry. 2013;84:931&#x2013;935. doi: 10.1136/jnnp-2012-304529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304529</ArticleId><ArticleId IdType="pubmed">23463871</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V., Bueno-De-Mesquita H.B., Vermeulen R., Andersen P.M., Kyrozis A., Linseisen J., Kaaks R., Allen N.E., Roddam A.W., Boshuizen H.C., et al. Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort. Ann. Neurol. 2009;65:378&#x2013;385. doi: 10.1002/ana.21653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21653</ArticleId><ArticleId IdType="pubmed">19399866</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J., McLaughlin R., Vajda A., Fogh I., Jones A., Westeneng H.J., Heverin M., van Eijk R., Robberecht W., Van Damme P., et al. Novel gender selective survival effect of C9orf72 in European ALS cohorts (P5. 093) Neurology. 2016;86:P5.093.</Citation></Reference><Reference><Citation>Glasmacher S.A., Wong C., Pearson I.E., Pal S. Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers. A Systematic Review and Meta-analysis. JAMA Neurol. 2020;77:367&#x2013;376. doi: 10.1001/jamaneurol.2019.3924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.3924</ArticleId><ArticleId IdType="pmc">PMC6865318</ArticleId><ArticleId IdType="pubmed">31738367</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G., Andrew A.S., Traynor B.J., Chi&#xf2; A., Butt T.H., Stommel E.W. Gene environment-time interactions in neurodegenerative diseases: Hypotheses and research approaches. Ann. Neurosci. 2018;25:261&#x2013;267. doi: 10.1159/000495321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495321</ArticleId><ArticleId IdType="pmc">PMC6470336</ArticleId><ArticleId IdType="pubmed">31000966</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>